Delivery Order SPE2DB22D1106-SPE2DB25FEYN1
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,754.64 to AmerisourceBergen Drug Corp for the supply of Veklury 100 mg vials. This award, issued on August 22, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of September 15, 2025. The contract is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $15,848.80 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Veklury 100 mg vials, with an ultimate completion date of October 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The company will perform this delivery order from its corporate office...
- This delivery order, awarded August 25, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Veklury 100 mg vials with a ceiling value of $2,377.32. The contract utilizes firm fixed pricing with an ultimate completion date of September 16, 2025, and is classified as a child contract under a larger indefinite delivery vehicle. The award was made through open competition with no set-aside designation, and performance will occur at the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $11,886.30 to AmerisourceBergen Drug Corp for the supply of Veklury 100 mg vials, a critical antiviral medication. The contract is non-competitive, firm fixed-price delivery order with an ultimate completion date of September 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $3,962.20 delivery order to AmerisourceBergen Drug Corp on May 22, 2025, for the supply of Veklury 100 mg vials. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location in Conshohocken, PA 19428....
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $27,236.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VEKLURY 100 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veklury 100 mg vials, valued at $7,924.40 under a firm fixed price contract type. This competitively awarded, non-set-aside delivery order has an ultimate completion date of September 16, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,924.40 on August 5, 2025, for the supply of Veklury 100 mg vials, an antiviral medication used in treating severe respiratory infections. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Veklury 100 mg vials, with a ceiling value of $7,924.40. This firm fixed-price delivery order, which is a child contract under a larger vehicle, is scheduled for completion by September 11, 2025, with performance occurring at the awardee's facility in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $27,236.80, is for the supply of VEKLURY 100 mg vials, a critical pharmaceutical product. This order is placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYN1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Veklury 100 mg vials, with a ceiling value of $15,848.80 and a firm fixed price contract structure. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, continues to serve as a critical vendor for federal medical procurement through its comprehensive pharmaceutical and medical supply portfolio. The company's extensive contract awards with the Defense Logistics Agency reflect its capability to fulfill competitive federal procurement requirements across a wide spectrum of therapeutic domains, supporting military healthcare systems and other government agencies worldwide. Veklury, an antiviral medication used in treating certain viral infections, represents one component of the company's ongoing supply operations for the Defense Health Agency and related military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 7/18/25 |